InpharmD™Advancing Major Depressive Disorder Treatment: Exxua™ (gepirone extended release) Approval and…InpharmD’s Monthly DI Corner7 min read·Nov 30, 2023----
InpharmD™Guidelines Updates for Opportunistic Infections in Adults with HIVInpharmD’s Monthly DI Corner12 min read·Nov 1, 2023----
InpharmD™Nirsevimab: A Promising Breakthrough in RSV PreventionInpharmD’s Monthly DI Corner10 min read·Sep 29, 2023----
InpharmD™Zuranolone: A Milestone in Postpartum Depression TreatmentWritten By InpharmD Drug Information Fellow, Muna Said5 min read·Aug 30, 2023----
InpharmD™Exploring the Therapeutic Potential of Metformin in Cirrhotic Patients with Diabetes: Safety…Written By InpharmD Drug Information Pharmacist: Dena Homayouneih11 min read·Aug 29, 2023----
InpharmD™Meet the InpharmD 2022 Fellows — Dena HomayouniehTake a moment to get to know our current InpharmD fellows and what their experiences have been like so far!3 min read·Nov 25, 2022----
InpharmD™Meet the InpharmD 2022 Fellows — Joy UgwuanyiTake a moment to get to know our current InpharmD fellows and what their experiences have been like so far!3 min read·Nov 23, 2022----
InpharmD™Meet the InpharmD 2022 Fellows — Larissa A. MelnykTake a moment to get to know our current InpharmD fellows and what their experiences have been like so far!2 min read·Nov 21, 2022----
InpharmD™SGLT2 Inhibitors — A New Solution for Heart Failure?Written by Dylan Brown, PharmD — Drug Information Specialist, InpharmD7 min read·Nov 11, 2022----
InpharmD™Yet Another Shortage? Alternatives to OxytocinInpharmD™ Clinical Literature Summaries — S4E24 min read·Oct 14, 2022----
